Citigroup’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1 Buy
+1
New +$1 ﹤0.01% 5661
2026
Q1
Sell
-1
Closed -$2 6246
2025
Q4
$2 Buy
+1
New +$2 ﹤0.01% 5932
2021
Q2
Sell
-200
Closed -$2K 6314
2021
Q1
$2K Buy
+200
New +$2.38K ﹤0.01% 6054
2016
Q1
Hold
0
7660
2015
Q4
Hold
0
7770
2015
Q2
Hold
0
7668
2015
Q1
Hold
0
7346
2014
Q4
Hold
0
6975
2014
Q3
Hold
0
6916
2014
Q2
Hold
0
6635
2014
Q1
Hold
0
7141
2013
Q4
Hold
0
7094

Other funds holding NSPR

Citigroup's NSPR Position: Q2 2026 in Review

Citigroup opened a new position in InspireMD (NSPR) in Q2 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #5661 among its holdings. This is a return to the name: Citigroup previously reported a position in NSPR as recently as Q4 2025.

Citigroup first reported a position in NSPR in Q1 2021 and has held it in 3 quarters since. The position peaked at $2K in Q1 2021. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Citigroup held 1 share of InspireMD worth $1 as of Q2 2026.
  • InspireMD was a new Citigroup position in Q2 2026.
  • InspireMD made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5661 holding.
  • Citigroup first reported a position in InspireMD in Q1 2021 and has held it in 3 quarters since.
  • Citigroup's InspireMD position peaked at $2K in Q1 2021.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.